REVIEW ARTICLE ABOUT MOLECULAR DETECTION OF BRAIN CANCER
Abstract
Brain cancer, also known as a brain tumor, occurs when abnormal cells grow rapidly in the brain or its surrounding tissues. Brain cancer can be primary, beginning in the brain, or metastatic, originating in other body parts like the lung, breast, skin, kidney, or colon. Brain cancer poses serious challenges due to the intricacies of the human brain itself, as well as the presence of the blood-brain barrier, which provides an effective shield against various substances in the bloodstream. An accurate diagnosis of a brain tumor is vital for treatment, which often requires invasive surgery. Therefore, a newer and more effective diagnostic approach is critical to improving clinical practice.
References
1. B. Ghaddar, B. Veeren, P. Rondeau, M. Bringart, et al., "Impaired brain homeostasis and neurogenesis in diet-induced overweight zebrafish: a preventive role from A. borbonica extract," Scientific Reports, vol. 10, no. 1, 2020, Nature.com. nature.com
2. W. Khalid, P. Gill, M. S. Arshad, A. Ali, et al., "Functional behavior of DHA and EPA in the formation of babies brain at different stages of age, and protect from different brain-related diseases," International Journal of Food Sciences, vol. 2022, Taylor & Francis, 2022. tandfonline.com
3. K.D. Miller, Q.T. Ostrom, C. Kruchko, N. Patil, et al., "Brain and other central nervous system tumor statistics, 2021," CA: a cancer journal for clinicians, vol. 71, no. 5, pp. 381-406, 2021, Wiley Online Library. wiley.com
4. L. R. Schaff and I. K. Mellinghoff, "Glioblastoma and other primary brain malignancies in adults: a review," Jama, 2023. [HTML]
5. L. Lv, Y. Zhang, Y. Zhao, Q. Wei, Y. Zhao, et al., "Effects of 1p/19q codeletion on immune phenotype in low grade glioma," Frontiers in Cellular Neuroscience, vol. 2021. frontiersin.org. frontiersin.org
6. Z Kong, C Jiang, Y Zhang, S Liu, D Liu, Z Liu, et al., "Thin-slice magnetic resonance imaging-based radiomics signature predicts chromosomal 1p/19q co-deletion status in grade II and III gliomas," Frontiers in Oncology, 2020. frontiersin.org
7. S. Rebouissou and J. C. Nault, "Advances in molecular classification and precision oncology in hepatocellular carcinoma," Journal of hepatology, 2020. sciencedirect.com
8. U. Testa, E. Pelosi, and G. Castelli, "Genetic alterations in renal cancers: Identification of the mechanisms underlying cancer initiation and progression and of therapeutic targets," Medicines, 2020. mdpi.com
9. N. M. Chrzanowska, J. Kowalewski, and M. A. Lewandowska, "Use of fluorescence in situ hybridization (FISH) in diagnosis and tailored therapies in solid tumors," Molecules, 2020. mdpi.com
10. M. Shorokhova, N. Nikolsky, and T. Grinchuk, "Chromothripsis—Explosion in Genetic Science," Cells, 2021. mdpi.com
11. E. Willscher, L. Hopp, M. Kreuz, M. Schmidt, S. Hakobyan, et al., "High-resolution cartography of the transcriptome and methylome landscapes of diffuse gliomas," Cancers, vol. 2021. mdpi.com. mdpi.com
12. Y. Otani, K. Satomi, Y. Suruga, J. Ishida, K. Fujii, "Utility of genome-wide DNA methylation profiling for pediatric-type diffuse gliomas," Brain Tumor Pathology, vol. 2023. Springer, 2023. okayama-u.ac.jp
13. L. Pla, F. Sancenon, M.C. Martínez-Bisbal, et al., "A gated material as immunosensor for in-tissue detection of IDH1-R132H mutation in gliomas," Sensors and Actuators B: Chemical, vol. 2021, Elsevier, 2021. sciencedirect.com
14. S. Dogan, D. Frosina, J.A. Geronimo, E. Hernandez, et al., "Molecular epidemiology of IDH2 hotspot mutations in cancer and immunohistochemical detection of R172K, R172G, and R172M variants," Human pathology, vol. 2020, Elsevier, 2020. nih.gov
15. P. Ellis, L. Moore, M.A. Sanders, T.M. Butler, S.F. Brunner, et al., "Reliable detection of somatic mutations in solid tissues by laser-capture microdissection and low-input DNA sequencing," Nature Communications, 2021. [HTML]
16. R. Wang, Y. Hozumi, C. Yin, and G. W. Wei, "Mutations on COVID-19 diagnostic targets," Genomics, 2020. sciencedirect.com
17. S. Kim, T. Chowdhury, H.J. Yu, J.Y. Kahng, C.E. Lee, et al., "The telomere maintenance mechanism spectrum and its dynamics in gliomas," Genome Medicine, vol. 2022, Springer, 2022. springer.com
18. MS Waitkus, EN Erman, ZJ Reitman, "Mechanisms of telomere maintenance and associated therapeutic vulnerabilities in malignant gliomas," Neuro-oncology, vol. 2024, academic.oup.com. [HTML]
19. T. Wu, H. Karimi-Maleh, E.N. Dragoi, P. Puri, D. Zhang, et al., "Traditional methods and biosensors for detecting disinfection by-products in water: A review," Environmental …, vol. 2023, Elsevier, 2023. [HTML]
20. NJP Wawryk, CB Craven, LKJ Blackstock, et al., "New methods for identification of disinfection byproducts of toxicological relevance: Progress and future directions," Journal of Environmental …, vol. 2021, Elsevier, 2021. [HTML]
21. L. K. Vestergaard, D. N. P. Oliveira, C. K. Høgdall, and E. V. Høgdall, "Next generation sequencing technology in the clinic and its challenges," Cancers, 2021. mdpi.com
22. S. Nabavi and F. Zare, "Identification of copy number alterations from next-generation sequencing data," Computational Methods for Precision Oncology, 2022. [HTML]
23. K. Kim, J. Lee, and M. H. Park, "Microbubble Delivery Platform for Ultrasound-Mediated Therapy in Brain Cancers," Pharmaceutics, 2023. mdpi.com
24. S. Schoen Jr, M.S. Kilinc, H. Lee, Y. Guo, "Towards controlled drug delivery in brain tumors with microbubble-enhanced focused ultrasound," Advanced Drug Delivery Reviews, Elsevier, 2022. sciencedirect.com
25. N. Jugniot, R. Bam, E.J. Meuillet, E.C. Unger et al., "Current status of targeted microbubbles in diagnostic molecular imaging of pancreatic cancer," Bioengineering & Translational Medicine, vol. 2021, Wiley Online Library. wiley.com
